CERVICAL CARCINOMA
Clinical trials for CERVICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CARCINOMA trials appear
Sign up with your email to follow new studies for CERVICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat tumors in early trial
Disease control TerminatedThis study tested a drug called bemarituzumab in 260 adults with solid tumors that have high levels of a protein called FGFR2b. The main goals were to see if the drug is safe and if it can shrink tumors. Participants had already tried other treatments without success.
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Experimental cell therapy for cervical cancer stalls after just 5 patients
Disease control TerminatedThis early-phase trial tested a new treatment called TC-E202 for people with advanced cervical cancer that had stopped responding to standard treatments. TC-E202 uses a patient's own immune cells, which are genetically modified in a lab to better recognize and attack cancer cells…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TCRCure Biopharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Personalized cell therapy shows promise for tough cervical cancers
Disease control TerminatedThis phase 2 study tested a personalized treatment called LN-145 for women with recurrent or advanced cervical cancer. The therapy uses a patient's own tumor-fighting immune cells, grown in a lab and infused back. The trial aimed to see if it could shrink tumors, but it was termi…
Matched conditions: CERVICAL CARCINOMA
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:04 UTC